zotepine for behavioural and psychological symptoms in dementia: an open-label study

CNS Drugs 2004; 18 (15): 1165 CORRESPONDENCE 1172-7047/04/0015-1165/$31.00/0 © 2004 Adis Data Information BV. All rights reserved. weeks, approximately 8 weeks) were not included in Zotepine for this retrospective analysis. A total of 24 patients fulfilled criteria for inclusion in the per-protocol Behavioural and analysis. Psychological Symptoms Michael K. Rainer Memory Clinic and Psychiatric Department, in Dementia: An Open- Donauspital, Sozialmedizinisches Zentrum Ost, Vienna, Austria Label Study Christine Kr ¨ uger-Rainer We would like to clarify the study design de- Memory Clinic and Psychiatric Department, scribed in our recently published paper on Donauspital, Sozialmedizinisches Zentrum Ost, zotepine. [1] Vienna, Austria To obtain data from ‘real life’ patients, we used a retrospective study design. Individual patient data Manfred Haushofer were extracted from the records of a pool of patients Memory Clinic and Psychiatric Department, who had dementia-related psychosis with behav- Donauspital, Sozialmedizinisches Zentrum Ost, ioural and psychological symptoms of dementia. Vienna, Austria These patients were treated with zotepine and were routinely visited and tested using standardised as- Hermann AM Mucke sessment tools and rating scales every month. Pa- H.M. Pharma Consultancy, Vienna, Austria tients were included in the per-protocol population if all assessments were available over a period of 2 Reference months. Patients for whom there were insufficient 1. Rainer MK, Mucke HAM, Kruger-Rainer C, et al. Zotepine for data for our outcome measures of interest at the behavioural and psychological symptoms in dementia: an defined assessment times (baseline, approximately 4 open-label study. CNS Drugs 2004; 18 (1): 49-55

Upload: manfred-haushofer

Post on 18-Mar-2017

219 views

Category:

Documents

3 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Zotepine for Behavioural and Psychological Symptoms in Dementia: An Open-Label Study

CNS Drugs 2004; 18 (15): 1165CORRESPONDENCE 1172-7047/04/0015-1165/$31.00/0

weeks, approximately 8 weeks) were not included inZotepine for this retrospective analysis. A total of 24 patientsfulfilled criteria for inclusion in the per-protocolBehavioural andanalysis.

Psychological Symptoms Michael K. RainerMemory Clinic and Psychiatric Department,in Dementia: An Open- Donauspital, Sozialmedizinisches Zentrum Ost,

Vienna, AustriaLabel Study Christine Kruger-Rainer

We would like to clarify the study design de-Memory Clinic and Psychiatric Department,

scribed in our recently published paper on Donauspital, Sozialmedizinisches Zentrum Ost,zotepine.[1]

Vienna, AustriaTo obtain data from ‘real life’ patients, we used a

retrospective study design. Individual patient data Manfred Haushoferwere extracted from the records of a pool of patients Memory Clinic and Psychiatric Department,who had dementia-related psychosis with behav- Donauspital, Sozialmedizinisches Zentrum Ost,ioural and psychological symptoms of dementia. Vienna, AustriaThese patients were treated with zotepine and wereroutinely visited and tested using standardised as- Hermann AM Muckesessment tools and rating scales every month. Pa- H.M. Pharma Consultancy, Vienna, Austriatients were included in the per-protocol population ifall assessments were available over a period of 2

Referencemonths. Patients for whom there were insufficient1. Rainer MK, Mucke HAM, Kruger-Rainer C, et al. Zotepine fordata for our outcome measures of interest at the behavioural and psychological symptoms in dementia: an

defined assessment times (baseline, approximately 4 open-label study. CNS Drugs 2004; 18 (1): 49-55

A set of behavioural symptoms that can be highly

Behavioural Symptoms of Dementia - Health Quality … | Quality Standards Behavioural Symptoms of Dementia: Care for Patients in Hospitals and Residents in Long-Term Care Homes About

Understanding & Responding to Behavioral Symptoms · PDF fileUnderstanding & Responding to Behavioral Symptoms in Dementia ... Behavioral symptoms in dementia are often troubling to

Management of Behavioral Symptoms in Alzheimer’s Dementia

The effectiveness of music therapy to reduce behavioural ... file · Web viewMusic therapy for neuropsychiatric symptoms in the general hospital: a systematic literature review. Dementia

[Infographic] Living with the Repetitive Symptoms of Dementia

Management of the Non-cognitive Symptoms of Dementia

Behavioural and Psychological Symptoms of Dementia Non-pharmacological and pharmacological approaches Dr Joy Ratcliffe, Consultant Psychiatrist Dr Julie

Behavioural and Psychological Symptoms of Dementia (BPSD) · Behavioural and Psychological Symptoms of Dementia (BPSD) “Alzheimer’s disease is the most widely encountered cause

Drugs for behavioural and psychological symptoms in dementia · 6 Drugs for behavioural and psychological symptoms in dementia. Once treatment has begun it is important that it is

Q3: For behavioural and psychological symptoms in people